Standardized pyrogen testing of medical products with the bacterial endotoxin test (BET) as a substitute for rabbit Pyrogen testing (RPT): A scoping review.

The Bacterial Endotoxin Test (BET) is a method for exclusion of endotoxin-related pyrogen contamination in pharmaceutical products, as an alternative to the Rabbit Pyrogen Test (RPT). However, BET does not detect a broad range of biologically relevant pyrogens, and interferences can limit its practical use for different medical products. This work aimed to scope the evidence in the scientific literature for case-by-case validity assessments of BET in different uses for medical products. A search strategy was conducted in PubMed, Scopus, and Web of Science in April 2020, according to the PRISMA-ScR statement. Twenty-two references were included, evaluating medical products for endotoxin contamination through both BET and RPT according to standardized protocols. A critical appraisal was performed through ToxRTool, followed by data extraction and qualitative synthesis of outcomes and methodological issues. Four classes of products assessed by BET were identified, including nanoparticles, drugs, blood and biological products. A considerable variation was observed on the BET methods used. Collectively, the evidence indicates different factors influencing the outcome of BET, including the chemical nature of samples that may cause interference depending on the selected method. While some applications to medical products appear adequate, others, such as nanoparticles, may require the use of different in vitro pyrogen testing methods, reinforcing the need for case-by-case validation for each BET method and type of medical product.

Empreender para inovar: oportunidades para atuação na ciência / Entrepreneurship to innovate: opportunities for action in science

Empreender para inovar abre novas possibilidades de aplicação dos conhecimentos adquiridos na academia para o desenvolvimento econômico e social no país. Para isso, é importante que todos os atores do ecossistema relacionados com a Tríplice Hélice da Inovação se integrem para a criação de um ambiente de inovação com mecanismos que auxiliem e acelerem o desenvolvimento sustentável do Brasil. O presente comentário pretende divulgar políticas e iniciativas relevantes dos setores públicos e privados para sua interlocução com vistas a fomentar o empreendedorismo e a inovação; bem como contribuir para a ampliação do conhecimento acerca das oportunidades para a atuação de cientistas nesse contexto.

Entrepreneurship to innovate opens new possibilities for applying knowledge acquired in academia for economic and social development in the country. For this, it is important that all actors in the ecosystem related to the Triple Helix of Innovation integrate to create an innovation environment with mechanisms that help and accelerate the sustainable development of Brazil. This commentary intends to disseminate relevant policies and initiatives from the public and private sectors for their dialogue with a view to fostering entrepreneurship and innovation; as well as contributing to the expansion of knowledge about the opportunities for the work of scientists in this context.

Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test.

Lipoteichoic acid (LTA) is a non-endotoxin pyrogen of a great importance in the pathogenesis of sepsis. The Rabbit Pyrogen Test (RPT) is able to detect all types of pyrogens but involves the use of animals. The Bacterial Endotoxin Test (BET) cannot fully replace the RPT because it only detects endotoxins. The Monocyte Activation Test (MAT) is sensitive to all types of pyrogens and it is based on the same biological mechanism that is responsible for the fever reaction in humans. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) has recommended its use for other pyrogens than endotoxin because its equivalence to RPT can be demonstrated. The aim of this study was to evaluate the pyrogenic responses of the RPT and MAT that was induced by LTA. Different LTA concentrations were assayed by the MAT in parallel to the RPT. The results showed that the MAT was more sensitive than the RPT, demonstrating that the MAT detected LTA. This result may contribute to the acceptance of this test by the Brazilian regulatory agencies as a replacement for the animals used in the RPT.

Influência do erro de micropipetas na dosagem espectrofotométrica do ensaio de endotoxina bacteriana (LAL cromogênico) aplicável a produtos sujeitos à Vigilância Sanitária / Effect of micropipette inaccuracy on performance of spectrophotometric assay for bacteria endotoxin dosage (chromogenic LAL) employed in products subjected to sanitary surveillance

Segundo a norma ISO 17.025, os instrumentos usados em experimento devem ser calibrados. No caso de micropipetas não há limite máximo de erro definido, sendo difícil estipular até que ponto uma micropipeta pode continuar a ser usada. O objetivo do trabalho foi o de determinar a porcentagem de erro no volume da micropipeta que não interfira nos resultados das diferentes etapas do ensaio toxicológico Lisado de Amebócitos de Limulus (LAL). Os percentuais de erro foram obtidos do levantamento de 44 certificados de micropipetas. Foram utilizados uma pipeta monocanal calibrada, de volume variável e kit LAL Cromogênio QCL-1000 (Lonza). A curva de endotoxina foi construída com as concentrações de 0,1; 0,25; 0,5 e 1 UE/mL. Os percentuais de erro de ±2%, ±4% e±10% foram comparados com a concentração de referência (0,5 UE/mL), e analisados pelo Student t-test (p<0,05). A análise estatística mostrou que, para a endotoxina padrão e para o substrato do LAL, erro acima de 2% interferenos resultados, cuja correção deve ser feita pelo ajuste do volume na pipeta. Nenhum erro testado causou interferência estatisticamente significativa na reação da cor do substrato. Micropipetas com erro superior a ±2% devem ser corrigidas.